ABCG2 and early-onset autosomal dominant Alzheimer disease: Excluding pathways with less than 50 total studies, the pathways with the highest proportion (> 88%) of AD-specific studies vs. dementia were ABC transporters, Alzheimer’s disease, the three O-glycan, and two glycosaminoglycan pathways (Figure 2).